Incidence and survival of patients with malignant pancreatic neuroendocrine neoplasms in Germany, 2009–2021
The incidence of pancreatic NETs has increased markedly in Germany in the period 2009-2021. Subgroups of NETs (G1 grading or localized stage) have an excellent prognosis. RS of MiNEN is more similar to NECs than NETs.
Authors
- Ian Wittenberg
- Ina Wellmann (ORCID: https://orcid.org/0009-0001-1831-2542)
- Soo-Zin Kim-Wanner
- Bernd Holleczek (ORCID: https://orcid.org/0000-0001-8759-4371)
- Jens Thomas Siveke (ORCID: https://orcid.org/0000-0002-8772-4778)
- Hiltraud Kajüter (ORCID: https://orcid.org/0000-0003-3729-4447)
- Jacqueline Müller‐Nordhorn (ORCID: https://orcid.org/0000-0001-7466-836X)
- Andreas Stang (ORCID: https://orcid.org/0000-0001-6363-9061)
- Eunice Sirri (ORCID: https://orcid.org/0000-0003-3278-8421)
Institutions
- Hess (United States) (US)
- Wittenberg University (US)
- Institut für Medizinische Informatik, Biometrie und Epidemiologie (DE)
- Health and Safety Authority (IE)
- Regio (Germany) (DE)
- Essen University Hospital (DE)
- Krebsregister Saarland (DE)
- West German Heart and Vascular Center Essen (DE)
Publication Details
- Journal
- Cancer Epidemiology
- Published
- 2024-09-06
- DOI
- https://doi.org/10.1016/j.canep.2024.102659
- Citations
- 11
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 4.25